Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Clinical trial NCT00088010 · COMPLETED

Trial details

NCT number: NCT00088010
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2004-06-01
Primary completion: 2009-06-01
Enrollment: 9369

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.